January 12, 2022Form of Release Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of General Counsel of Alumis Inc. (the “Company”),. This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ContractAlumis Inc. • June 7th, 2024 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant customarily and actually treats as private or confidential.
AMENDMENT TO OFFER LETTEROffer Letter • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
This Amendment to Offer Letter is made and entered into effective as of July 17, 2023 (the “Amendment Effective Date”), by and between Alumis Inc., a company organized under the laws of Delaware (the “Company”), and its Chief Development Officer Mark Bradley.
STOCK PURCHASE AGREEMENT dated as of March 5, 2021 by and among FL2021-001, INC., AS PURCHASER, FRONTHERA INTERNATIONAL GROUP LIMITED, AS SELLER AND FRONTHERA U.S. HOLDINGS, INC., AS THE COMPANYStock Purchase Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 5, 2021 by and among (i) FL2021-001, Inc., a Delaware corporation (“Purchaser”); (ii) FronThera International Group Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Seller”); and (iii) FronThera U.S. Holdings, Inc., a Delaware corporation (the “Company”). Purchaser, Seller and the Company will be individually referred to herein as a “Party” and collectively referred to herein as the “Parties”.
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • June 7th, 2024 • Alumis Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 4th day of March, 2024 by and among Alumis Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.
SUMMARY OF BASIC LEASE INFORMATIONAlumis Inc. • June 7th, 2024 • Pharmaceutical preparations • California
